subrosa Health and Capital India

subrosa Health and Capital India is a global strategic consulting and end-to-end service organization deeply invested in the research and commercialization of rare disease and orphan drugs. Focusing on therapies for gene-based diseases, subrosa Health and Capital India helps biotech companies unlock business opportunities and identify new molecules and patients, thereby de-risking investments. With a commitment to innovation and growth, subrosa Health and Capital India delivers comprehensive solutions that drive success in the rare disease sector.

subrosa Health and Capital India excels in commercial operations and market access, providing remote and hybrid channels for HCP & Patient Engagement. subrosa Health and Capital India assists Pharma and Biotech companies in M&A and Global partnering, offering patient identification services for existing portfolios and patient recruitment for ongoing Clinical Trials through subrosa PRO+. With a global presence, subrosa Health and Capital India is dedicated to advancing the development and accessibility of orphan drugs worldwide.

With primary offices in Chennai, IN, and additional locations in Munich, DE, and Zug, CH, subrosa Health and Capital India is strategically positioned to serve a global clientele. subrosa Health and Capital India is dedicated to accelerating the commercialization of rare disease therapies and improving patient outcomes. We invite the manager of subrosa Health and Capital India to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.